-amino-acid residue 129 of PrP, which can be either methionine (M) or V. It is thought that one copy of each 129 variant confers some resistance to human prion diseases by affecting the binding between identical prion proteins that is required for conformational change. The researchers injected human prions into mice engineered to express human forms of PrP harbouring different combinations of the two genetic variants.
Mice with one copy of V127 were completely protected against kuru prions, and died of old age without developing neurological disease. By contrast, all mice without V127 developed disease after around 200 days, regardless of the variant at residue 129, confirming that this model system accurately recapitulates the resistance to kuru conferred by V127. Previous work 5 has indicated that the transmission properties of kuru are similar to those of the sporadic form of CJD (sCJD), and so it probably came as no surprise to the authors to find that mice with one copy of V127 were also protected from sCJD prions. Interestingly, however, not all of these mice were protected against vCJD prions.
Remarkably, mice carrying two copies of V127 were completely protected against all forms of human prion disease (Fig. 1) , indicating that the polymorphism at residue 127 acts in a different manner from that at 129. These mice failed to manifest any signs of prion disease, a noteworthy response that was mimicked only in mice that did not express any prion protein. Finally, Asante et al. investigated how the protective effect of one copy of V127 varied when wild-type PrP (in which the genetic sequence includes the G127 and M129 variants) was expressed at different levels. These experiments demonstrated that V127 acts as a 'dominant negative' inhibitor of prion conversion -not only is it itself resistant to conformational conversion, but it also inhibits conversion of wild-type proteins.
It will be important to learn what structural consequences, if any, occur when V replaces G at residue 127. There are currently no treatments or cures for transmissible spongiform encephalopathies, and structural information may hint at ways to inhibit PrP Sc propagation and maintain normal PrP C function. Approaches that capitalize on the profound dominant-negative properties of V127 are obvious targets for further investigation.
V127 was naturally selected in response to epidemic human prion disease. In a similar manner to DNA-or RNA-based infectious agents, prions are subject to Darwinian forces, such that the structure of the disease-causing protein can be altered through selective pressure 6 . This begs the question of whether new prion strains might emerge to counter the protective effects of the V127 variant. It will be interesting to determine whether V127 also prevents conformational changes in PrP in experimental models of prion amplification, which have been shown to enable interspecies prion transmission 7 , and if so, what the infectious properties of the resulting prions might be. Finally, it will be valuable to investigate the V127 polymorphism in the context of PrP from other species that are naturally susceptible to prion diseases, using similar approaches to those in the current study. This should help to ascertain whether the effects of this fascinating variant are universally protective against all combinations of species and prion strains. PLANT SCIENCE
Precision positioning with peptides
Two related peptides compete for binding to the same receptor to regulate the spacing of cells on the lower surfaces of leaves. This discovery highlights the complexity of cell signalling in plants. See Article p.439
eing fixed in position, plants must be able to respond to a multitude of environmental and developmental inputs over appropriate time frames. To do this, they use organic molecules such as auxin or ethylene, as well as signalling molecules analogous to those used in animals, including peptides (short strings of amino acids) and hormones. But plant peptide signalling pathways, particularly interactions between peptides and their receptor proteins, are poorly understood. In this issue, Lee et al. 1 (page 439) define a plant signalling pathway in which two peptides compete for binding to one receptor, exerting opposing effects on the development of tiny openings called stomata on the lower surfaces of leaves.
Stomata regulate the passage of oxygen, carbon dioxide and water vapour in and out of the leaf. These pores are surrounded by two guard cells, which mediate stomatal opening and closing in response to the time of day, to changes in the environment or to physical changes in the plant itself. Guard cells originate . ER activation by the peptide EPF2, which is secreted from cells that have already become meristemoids, suppresses the meristemoid-guard-cell lineage in adjacent cells. By contrast, the peptide Stomagen, which is produced in the overlying mesophyll cell layer, inhibits activation of ER and so promotes guard-cell differentiation. Lee et al. 1 report that EPF2 and Stomagen compete for binding to ER, to regulate the even spacing of guard cells between pavement cells. from precursors called protodermal cells. Protodermal cells can either proliferate to give rise to pavement cells, which make up the protective epidermis covering the surface of the leaf, or differentiate into a meristemoid mother cell (MMC), a progenitor of the guard cell. MMCs divide asymmetrically, one daughter cell becoming a meristemoid, the other becoming a stomatal-lineage ground cell, a progenitor that can either differentiate into pavement cells or, through a 'spacing division' , give rise to a second, satellite meristemoid cell. Meristemoids then undergo asymmetric divisions, and finally differentiate into pairs of guard cells that are evenly distributed between pavement cells (Fig. 1) . But what governs these cell-fate decisions?
Mutations in genes encoding receptor proteins of the ERECTA (ER) family cause a loss of control over stomatal spacing, leading to the development of leaves with unevenly spaced stomata. The severity of this trait is further influenced by mutations in an ER co-receptor, TOO MANY MOUTHS (TMM), demonstrating that ER-family signalling is a key regulator of stomatal development. ER-family receptors are activated by EPIDERMAL PATTERNING FACTOR 1 (EPF1) and EPF2, peptides that exert different, but overlapping, effects on stomatal development. By signalling through the receptor ER-LIKE 1 (ERL1), EPF1 orients stomatal spacing and prevents differentiation into guard cells, whereas EPF2-ER signalling restricts the formation of this lineage at an earlier stage. Both receptors exert their effects by activating an intracellular signalling cascade called the MAPK pathway (reviewed in ref. 2) .
In contrast to EPF1 and EPF2, the EPF-like peptide Stomagen promotes stomatal development by inducing guard-cell differentiation 3 . Lee et al. set out to investigate how these related peptides could exert such dramatically opposing effects. The authors found that the altered stomatal differentiation that occurs in plants harbouring mutant forms of the genes encoding ER, ERL1 or TMM was not affected by the addition of Stomagen. This suggests that Stomagen, like EPF1 and EPF2, acts through ER-family receptors.
Lee and colleagues then provided extensive genetic evidence to support this idea. By inhibiting or overexpressing the gene encoding Stomagen, the authors showed that misexpression of the peptide interferes with all signalling pathways mediated by the ER family. Next, using sophisticated genetic and in vitro biochemical experiments, they confirmed that Stomagen actively competes with EPF2 for ER, the two peptides binding to the receptor with similar affinities. Finally, the researchers showed that Stomagen could not activate MAPK signalling. They propose that binding of Stomagen to ER-family receptors actually prevents MAPK signal transduction.
These results provide evidence that a finely balanced system of closely related activating and inhibitory peptides locally modulates the signalling pathways required for proper stomatal spacing in the plant epidermis (Fig. 1) . One uncertainty in this model is the similarity in the dissociation constants (a measure of the binding strength between two proteins) of EPF2-ER and Stomagen-ER. This implies that massive changes in the local concentration of one ligand, or a large adjustment in the ligand's local receptor sensitivity, would be needed to induce a change in stomatal patterning. Which mechanism is used in physiological conditions is an issue that clearly needs to be addressed.
A competitive inhibition mechanism provides precise control of cellular spacing, analogous to the 'lateral inhibition' mechanism that regulates the spacing of animal cells. It is now imperative to determine whether similar mechanisms operate over time to generate repetitive differentiation events periodically during plant development. For example, systems such as the CLE40-CLV1-ACR4 signalling pathway, which regulates stemcell maintenance in the growing tips and roots of plants 4 , might use a similar combination of activators and inhibitors. Future studies should also analyse whether local changes in the levels of particular peptide combinations could weave a 3D pattern of locally activating and inhibitory signalling conditions.
The results of the current study can be put in the larger context of plant signalling pathways -which includes different combinations of ligands, receptors and co-receptors -acting in conjunction with local changes in signalling pathways mediated by organic molecules. Furthermore, because there is evidence for a direct connection between plant steroid signalling and the stomatal pathway 5 , yet another level of signalling seems plausible. A picture emerges in which almost every cell in a plant tissue can be exposed to a precisely defined set of signals. This new concept in plant spatial control should now be tested in other settings. ■ 
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